CARDIOCEQ Trademark

Trademark Overview

On Wednesday, June 2, 2021, a trademark application was filed for CARDIOCEQ with the United States Patent and Trademark Office. The USPTO has given the CARDIOCEQ trademark a serial number of 79319894. The federal status of this trademark filing is REGISTERED as of Tuesday, March 21, 2023. This trademark is owned by Life Molecular Imaging Ltd.. The CARDIOCEQ trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations for medical purposes; diagnostic materials in the nature of reagents for medical purposes; diagnostic agents for medical use
cardioceq

General Information

Serial Number79319894
Word MarkCARDIOCEQ
Filing DateWednesday, June 2, 2021
Status700 - REGISTERED
Status DateTuesday, March 21, 2023
Registration Number7002519
Registration DateTuesday, March 21, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements

Goods and ServicesDiagnostic preparations for medical purposes; diagnostic materials in the nature of reagents for medical purposes; diagnostic agents for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLife Molecular Imaging Limited
Party Type31 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressGB
Party NameLife Molecular Imaging Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameLife Molecular Imaging Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameLife Molecular Imaging Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, September 9, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, September 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 18, 2021APPLICATION FILING RECEIPT MAILED
Thursday, February 17, 2022ASSIGNED TO EXAMINER
Tuesday, February 22, 2022NON-FINAL ACTION WRITTEN
Wednesday, February 23, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 23, 2022REFUSAL PROCESSED BY MPU
Wednesday, March 23, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 11, 2022REFUSAL PROCESSED BY IB
Thursday, September 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 14, 2022FINAL REFUSAL WRITTEN
Friday, October 14, 2022FINAL REFUSAL E-MAILED
Friday, October 14, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 28, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, November 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 15, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, February 15, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, March 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, March 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 21, 2023REGISTERED-PRINCIPAL REGISTER
Friday, June 16, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, June 21, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 27, 2023FINAL DISPOSITION PROCESSED
Wednesday, June 28, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 21, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 9, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB

Related Keywords

cardioceq diagnostic medical purposes agents reagents nature materials preparations